go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Pfizer Healthcare Ireland
9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24,
Telephone: +353 1 467 6500
Fax: +353 1 467 6501
Medical Information Direct Line: 1 800 633 363
Patient Information Leaflet last updated on medicines.ie: 21/10/2011
PIL ENBREL 25 mg powder and solvent for solution for injection.

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 21/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to storage instructions
Updated on 23/09/2011 and displayed until 21/10/2011
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 23/08/2011 and displayed until 23/09/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to marketing authorisation holder
Updated on 22/07/2011 and displayed until 23/08/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 10/06/2011 and displayed until 22/07/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 31/05/2011 and displayed until 10/06/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 08/03/2011 and displayed until 31/05/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 04/02/2011 and displayed until 08/03/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 16/12/2010 and displayed until 04/02/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 30/07/2010 and displayed until 16/12/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 05/07/2010 and displayed until 30/07/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to MA holder contact details
Updated on 18/01/2010 and displayed until 05/07/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to MA holder contact details
Updated on 26/08/2009 and displayed until 18/01/2010
Reasons for adding or updating:
  • Change to improve clarity and readability
Updated on 17/07/2009 and displayed until 26/08/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 10/06/2009 and displayed until 17/07/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 03/10/2008 and displayed until 10/06/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Addition of marketing authorisation holder
Updated on 01/08/2008 and displayed until 03/10/2008
Reasons for adding or updating:
  • Change to dosage and administration
  • Change to drug interactions
Updated on 20/12/2007 and displayed until 01/08/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 15/10/2007 and displayed until 20/12/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to further information section
  • Change to dosage and administration
Updated on 07/02/2007 and displayed until 15/10/2007
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 18/12/2006 and displayed until 07/02/2007
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 27/10/2006 and displayed until 18/12/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to further information section
  • Change to dosage and administration
  • Change to storage instructions
Updated on 13/07/2006 and displayed until 27/10/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to further information section
  • Change to dosage and administration
  • Change to date of revision
Updated on 27/09/2005 and displayed until 13/07/2006
Reasons for adding or updating:
  • Change of manufacturer
  • Change to, or new use for medicine
Updated on 09/05/2005 and displayed until 27/09/2005
Reasons for adding or updating:
  • Change to information about driving or using machinery
  • Change to storage instructions
  • Change to further information section
  • Change to appearance of the medicine
  • Change to dosage and administration
Updated on 08/12/2004 and displayed until 09/05/2005
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to drug interactions
Updated on 26/08/2004 and displayed until 08/12/2004
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Etanercept